Skip to main content
. 2015 Aug 13;6(25):20813–20828. doi: 10.18632/oncotarget.5175

Table 2. Cox regression analysis of Rab1A expression and clinicopathologic features in cohort I and cohort II.

Clinical parameters Univariate analysis Multivariate analysis
RR 95% CI p value RR 95% CI p value
Chort I
Rab1A Exp (High vs Low) 7.863 3.128-19.768 <0.001 7.247 2.833-18.539 <0.001
Age (≤60 vs >60) 0.982 0.961-1.004 0.114 0.999 0.978-1.020 0.911
Gender (Female vs Male) 0.810 0.409-1.607 0.547 1.065 0.490-2.312 0.874
TNM Stage (III vs I-II) 5.613 3.242-9.719 <0.001 4.104 2.041-8.251 <0.001
Tumor Size (cm) (>5 vs ≤5) 1.684 0.931-3.044 0.085 1.210 0.635-2.306 0.561
Tumor Number (>1 vs 1) 3.099 1.803-5.325 <0.001 1.069 0.727-1.574 0.734
Recurrence (Yes vs No) 2.895 1.657-5.057 <0.001 2.612 1.450-4.705 0.002
Chort II
Rab1A Exp (High vs Low) 1.726 1.465-2.986 0.009 2.289 1.224-4.281 0.010
Age (≤60 vs >60) 0.929 0.551-1.566 0.782 0.962 0.570-1.625 0.885
Gender (Female vs Male) 1.253 0.500-3.141 0.619 1.327 0.522-3.370 0.353
TNM Stage (III vs I-II) 2.409 1.410-4.116 0.001 2.342 1.260-4.351 0.007
tumor Size (cm) (>5 vs ≤5) 2.106 1.195-3.709 0.010 1.212 0.633-2.323 0.562
Tumor Number (>1 vs 1) 1.514 0.648-3.533 0.338